Literature DB >> 1367357

High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep.

G Wright1, A Carver, D Cottom, D Reeves, A Scott, P Simons, I Wilmut, I Garner, A Colman.   

Abstract

We describe the generation of five sheep transgenic for a fusion of the ovine beta-lactoglobulin gene promotor to the human alpha 1-antitrypsin (h alpha 1AT) genomic sequences. Four of these animals are female and one male. Analysis of the expression of h alpha 1AT in the milk of three of these females shows that all express the human protein at levels greater than 1 gram per liter. In one case initial levels exceeded 60 grams per liter and stabilized at approximately 35 grams per liter as lactation progressed. Human alpha 1AT purified from the milk of these animals appears to be fully N-glycosylated and has a biological activity indistinguishable from human plasma-derived material.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367357     DOI: 10.1038/nbt0991-830

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  67 in total

Review 1.  The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins.

Authors:  A J Clark
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Fish as bioreactors: transgene expression of human coagulation factor VII in fish embryos.

Authors:  Gyulin Hwang; Ferenc Müller; M Aziz Rahman; Darren W Williams; Paul J Murdock; K John Pasi; Geoffrey Goldspink; Hamid Farahmand; Norman Maclean
Journal:  Mar Biotechnol (NY)       Date:  2004-04-29       Impact factor: 3.619

3.  Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus.

Authors:  K W Dobie; M Lee; J A Fantes; E Graham; A J Clark; A Springbett; R Lathe; M McClenaghan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 4.  Somatic cell nuclear transfer: origins, the present position and future opportunities.

Authors:  Ian Wilmut; Yu Bai; Jane Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

5.  The increased expression of follicle-stimulating hormone leads to a decrease of fecundity in transgenic Large White female pigs.

Authors:  Kai Jiang; Pan Xu; Wanbo Li; Qiang Yang; Longyun Li; Chuanmin Qiao; Huanfa Gong; Hao Zheng; Zhimin Zhou; Hao Fu; Qiuyan Li; Yuyun Xing; Jun Ren
Journal:  Transgenic Res       Date:  2017-06-19       Impact factor: 2.788

Review 6.  Animal transgenesis: state of the art and applications.

Authors:  Eduardo O Melo; Aurea M O Canavessi; Mauricio M Franco; Rodolfo Rumpf
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

7.  Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice.

Authors:  F Yull; G Harold; R Wallace; A Cowper; J Percy; I Cottingham; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Generation of mastitis resistance in cows by targeting human lysozyme gene to β-casein locus using zinc-finger nucleases.

Authors:  Xu Liu; Yongsheng Wang; Yuchen Tian; Yuan Yu; Mingqing Gao; Guangdong Hu; Feng Su; Shaohui Pan; Yan Luo; Zekun Guo; Fusheng Quan; Yong Zhang
Journal:  Proc Biol Sci       Date:  2014-02-19       Impact factor: 5.349

9.  High level production of human growth hormone in the milk of transgenic mice: the upstream region of the rabbit whey acidic protein (WAP) gene targets transgene expression to the mammary gland.

Authors:  E Devinoy; D Thépot; M G Stinnakre; M L Fontaine; H Grabowski; C Puissant; A Pavirani; L M Houdebine
Journal:  Transgenic Res       Date:  1994-03       Impact factor: 2.788

10.  Expression of human lactoferrin in milk of transgenic mice.

Authors:  G J Platenburg; E P Kootwijk; P M Kooiman; S L Woloshuk; J H Nuijens; P J Krimpenfort; F R Pieper; H A de Boer; R Strijker
Journal:  Transgenic Res       Date:  1994-03       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.